Navigation Links
PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
Date:4/30/2013

$0.33 per diluted share in the quarter ended March 31, 2012.  Adjusted earnings per share grew 51.5% year-over-year.

The GAAP tax rate for the third quarter of Fiscal Year 2013 was 17.6% compared with negative 4.2% in the prior year quarter.  Excluding special items as detailed in the financial charts within this press release, the adjusted tax rate in the March 2013 quarter was 19.6%, compared with 16.4% in the March 2012 quarter.  The third quarter tax rate included the impact of U.S. tax law changes enacted in January 2013, which were retroactive for the Company to July 1, 2012, as well as certain other favorable adjustments.  Going forward, the Company expects the GAAP tax rate for the fourth quarter of Fiscal Year 2013 to be in the 30% range, and to be approximately 27-28% for the full year.

During the third quarter, the Company finalized the settlement of the first $50 million Accelerated Share Repurchase Program (which had been announced in September 2012) and received approximately 235,000 additional shares.

As previously announced on March 14, 2013, the Company authorized a second $50 million Accelerated Share Repurchase Program.  On March 15, 2013, $50 million was paid out and an initial allotment of approximately 1.04 million shares was received by the Company.  The Company expects to receive additional shares once the program is completed.  With regard to a second $50 million  10b5-1 open market program that was also announced in mid-March, PAREXEL purchased approximately 32,200 shares during the third quarter, at a cost of approximately $1.3 million.  Taking into account Fiscal Year activity to date, as of March 31, 2013, approximately $48.7 million remained available under the $200 million authorized Share Repurchase Program for the purchase of additional shares. 

On a segment basis, service revenue for the third quarter of Fiscal Year 2013 was $342.4 million in Clinical Res
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
2. PAREXEL International to Present at J.P. Morgan Healthcare Conference
3. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
4. PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
5. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
6. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
7. PAREXEL International Reports First Quarter Fiscal Year 2013 Results
8. PAREXEL International to Present at Morningstar Conference
9. PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
10. UV Flu Technologies Expands Its International Footprint
11. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Scottsdale, AZ (PRWEB) July 11, 2014 ... medicine device company specializing in the soft tissue ... SureLock All-Suture Anchor System for surgeries involving the ... predictable fixation through a novel, inserter-controlled deployment method. ... lead to partial deployment, anchor pull-out, or anchor ...
(Date:7/10/2014)... Understanding the need for better quality ... the gap that currently exists in this area, ChanTest ... portfolio of validated ion channel and GPCR cell lines. ... as ion channels control many critical physiological functions throughout ... the potential to treat a variety of human diseases. ...
(Date:7/10/2014)... 2014 OMICS Group’s 5th International conference ... August, 2014 at Double Tree by Hilton Beijing, China ... in Analytical & Bioanalytical research methods only to facilitate ... this occasion, Dr. Srinubabu Gedela, MD of OMICS Group ... a remarkable one in bringing a unique and international ...
(Date:7/10/2014)... Russia , July 10, 2014 ... Federation Dmitry Medvedev , presented Russia,s ... company BIOCAD . The Company is developing a ... of MabNext project BIOCAD develops a number of innovative ... and autoimmune diseases. The ceremony took place at the ...
Breaking Biology Technology:Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2
... 4 Cerimon,Pharmaceuticals, Inc. announced today that Matthew ... established position, and Vice President of,Business Development and ... and corporate attorney with broad experience with large,pharmaceutical, ... and,Europe. In the business development role, he replaces ...
... Approved for Marketing in the United States, Trade Name Will be ... ... Daiichi Sankyo,Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: ... New Drug,Application (NDA) for prasugrel to the U.S. Food and Drug Administration,(FDA). ...
... Inc.,(Nasdaq: THRM ), a leader in non-invasive ... it will present at the 10th Annual Needham ... New York City. The,Company,s presentation is scheduled for ... Stephen J. Fanning, Chairman, President and Chief,Executive Officer, ...
Cached Biology Technology:Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing 2Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 2Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 3Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 4
(Date:7/11/2014)... from The Chinese University of Hong Kong, BGI and ... linked to salt tolerance, with implication for improving this ... published online in Nature Communications provides an ... improvement. , Soybean is an important crop for the ... have less genetic diversities than their wild counterparts. Among ...
(Date:7/11/2014)... other group members to reduce aggression and gain access ... for grooming activities shows a certain pattern across the ... journal Biology Letters . , Grooming between individuals ... ulterior motives. To be groomed has hygienic benefits and ... individual can provide access to infants, mating opportunities and ...
(Date:7/11/2014)... University, Sweden, have explored two different ways that ... leading to the formation of oxygen molecules in ... the scientific journal Nature Communications . , ... synthetic catalysts for water oxidation, which are key ... direct storage of solar energy in fuels like ...
Breaking Biology News(10 mins):BGI reports a novel gene for salt tolerance found in wild soybean 2Baboons groom early in the day to get benefits later 2Molecular snapshots of oxygen formation in photosynthesis 2
... cold groundwater close to hot groundwater, and controlling mineral ... University of Catalonia and the University of Barcelona, after ... all by arsenic pollution. In this region, which is ... well as in other Catalan coastal mountain ranges, uranium ...
... Fla. --- The discovery of two new extinct camel species ... history of the tropics, a region containing more than half ... Appearing online this week in the Journal of ... of a fossil mammal discovered as part of an international ...
... to lead wreaks havoc in the brain, with consequences ... But the precise mechanism by which lead alters nerve ... New research led by Toms R. Guilarte, PhD, Leon ... Columbia University Mailman School of Public Health, and post-doctoral ...
Cached Biology News:Contamination of La Selva geothermal system in Girona, Spain 2Contamination of La Selva geothermal system in Girona, Spain 3UF scientists name new ancient camels from Panama Canal excavation 2UF scientists name new ancient camels from Panama Canal excavation 3In what ways does lead damage the brain? 2
... Histone Deacetylase (HDAC) Antibody Sampler Kit ... (HDAC1) Antibody, Catalog #2062, 40 ul Histone ... ul Histone Deacetylase 4 (HDAC4) Antibody, Catalog ... Antibody, Catalog #2082, 40 ul Histone Deacetylase ...
An instrument that delivers an accurate and uniform amount of light energy to cells to photoactivate csiRNA products....
... Quickly, effectively seals labware. Waterproof, moisture-proof ... anhydrous materials. Can be folded repeatedly ... rupturing. Stretched lengthwise at 21C (70F), ... when tension is removed, film only ...
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Biology Products: